Support & Solvents
Injection Kit
50 syringes + 100 padsEverything required to safely reconstitute and inject reconstituted peptides — 50 sterile insulin syringes plus 100 alcohol prep pads.
$25
Lyophilisé · 5 mg + 5 mg / vial
Healing & Recovery
5 mg + 5 mg / vial
BPC-157 + TB-500 Blend (5mg + 5mg) — Wolverine Stack
Co-lyophilized healing duo · Vascular + structural recovery · One injection
Premium Grade
Meilleures ventes
Co-lyophilized healing stack — the canonical pairing of gastric pentadecapeptide and thymosin fragment for tissue support.
- Numéro CAS
- Blend
- Poids moléculaire
- Mixed (1 420 + 4 963 Da)
- Pureté
- ≥ 99.0% (HPLC, each component)
- Stockage
- −20 °C, lyophilisé
Séquence d'acides aminés
BPC-157 (GEPPPGKPADDAGLV) co-lyophilized with TB-500 fragment
Gratuit pour les commandes de plus de $59$7.99 vers les États-Unis (48h) · $14.99 dans le monde (5 jours ouvrés)
Emballage discretEnveloppe isotherme discrète, aucun nom de composé à l'extérieur.
Certificat d'analyse
Rapport analytique par lot — HPLC, ESI-MS, endotoxine LAL, métaux lourds, stérilité
Lot actuelBPC853
Libéré2026-04-15
Pureté HPLC99.59%
Endotoxine (LAL)Réussi · < 0,5 EU/mg
À propos de BPC-157 + TB-500 Blend
Buy the BPC-157 + TB-500 blend at IGF1 Shop — the canonical "Wolverine stack" combining two of the most studied recovery peptides in a single vial. 5mg of BPC-157 (Body Protection Compound) is co-lyophilized with 5mg of TB-500 (Thymosin Beta-4 fragment) in a 1:1 mass ratio. BPC-157 contributes pentadecapeptide cytoprotection while TB-500 contributes actin remodeling and angiogenesis — a complementary mechanistic profile that covers both initiation and propagation phases of the repair cascade. Each component is HPLC ≥99% pure, ESI-MS verified, with a per-lot Certificate of Analysis from an ISO 17025 lab.
Également connu sous le nom de : BPC-157 TB-500 blend · Wolverine stack · BPC TB blend · Healing stack
BPC-157 + TB-500 Blend — Mécanisme & Spécifications
This blend combines two of the most studied healing peptides in a single vial. BPC-157 contributes pentadecapeptide cytoprotection while TB-500 contributes thymosin-fragment-driven actin remodeling and angiogenesis — a complementary mechanistic profile in one preparation.
Qualité & critères de libération
Chaque lot de BPC-157 + TB-500 Blend n'est libéré qu'après avoir réussi l'HPLC en phase inverse (≥ 99% de pureté aire à 220 nm par rapport à un standard de référence), la confirmation spectrométrie de masse ESI du poids moléculaire, et le test d'endotoxines LAL (Limulus Amebocyte Lysate) en dessous de 0,5 EU/mg. Le Certificat d'analyse spécifique au lot est fourni avec la commande et disponible sur demande avant achat.
$87
3 flacons · $29/flacon
FAQ
BPC-157 + TB-500 Blend — Questions fréquentes
What is in the BPC-157 + TB-500 blend?
Each vial contains 5mg of BPC-157 and 5mg of TB-500 co-lyophilized in a single vial — 10mg total peptide mass. Both peptides are synthesized separately to ≥99% HPLC purity, identity-confirmed by ESI-MS, then combined in a 1:1 mass ratio before final lyophilization. No fillers, no excipients beyond a trace mannitol cryoprotectant standard for peptide lyophilization.
Why combine BPC-157 with TB-500?
The two peptides act on complementary recovery pathways. BPC-157 supports nitric oxide signaling, growth-factor recruitment, and early-phase vascular repair. TB-500 amplifies cellular migration and structural remodeling via actin regulation. Combining BPC-157 + TB-500 covers both the initiation and the propagation phases of the repair cascade from a single injection.
What is the typical dose for the BPC + TB blend?
A common reference protocol is 250mcg BPC-157 + 250mcg TB-500 once daily during a loading phase, then 250mcg of each twice weekly for maintenance. Reconstituting 10mg total in 2mL of bacteriostatic water yields 500mcg of each peptide per 0.1mL. Adjust dose and frequency according to your own goals and existing protocols.
Is the blend more cost-effective than two separate vials?
Yes. The BPC-157 + TB-500 blend SKU prices below the combined cost of one TB-500 5mg vial and one BPC-157 5mg vial, and it cuts your injection count in half. The trade-off is that the dose ratio is fixed at 1:1 — if you want an asymmetric protocol, buy the singles.
How do I reconstitute the blend?
Add 2mL of bacteriostatic water slowly to the vial, swirl until fully clear, and refrigerate. At 2mL volume each 0.1mL contains 500mcg of BPC-157 and 500mcg of TB-500. The reconstituted solution is stable refrigerated for ~30 days; the dry vial is stable for 24 months sealed.
How long is a typical Wolverine stack cycle?
Loading cycles commonly run 4-8 weeks. Maintenance phases of 2-4 weeks may follow, with a wash-out period before re-cycling. Users targeting a specific injury frequently report shorter, more aggressive cycles; those running it for long-term joint maintenance favor lower, less-frequent dosing.
Is each batch tested?
Every batch of the BPC-157 + TB-500 blend ships with three documents on its COA: HPLC purity ≥99% per peptide, ESI-MS molecular weight confirmation, and LAL endotoxin <0.5 EU/mg. Testing is performed in ISO 17025-accredited third-party labs. The batch number is laser-printed on the vial.
Can I stack the blend with GHK-Cu or KPV?
Yes — that combination is the basis of our GLOW (70mg, +GHK-Cu) and KLOW (80mg, +GHK-Cu +KPV) blends. If you want one injection covering vascular, structural, and anti-inflammatory pathways, the pre-blended SKU is usually cleaner than mixing vials manually.
